Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0620920100420030216
Experimental & Molecular Medicine
2010 Volume.42 No. 3 p.216 ~ p.222
A double point mutation in PCL-¥ã1 (Y509A/F510A) enhances Y783 phosphorylation and inositol phospholipid-hydrolyzing activity upon EGF stimulation
Chung Sang-Hee

Kim Sung-Kuk
Kim Jung-Kuk
Yang Yong-Ryoul
Suh Pann-Ghill
Chang Jong-Soo
Abstract
Growth factor stimulation induces Y783 phosphorylation of phosphoinositide-specific PLC-¥ã1, and the subsequent activation of this enzyme in a cellular signaling cascade. Previously, we showed that a double point mutation, Y509A/F510A, of PLC-¥ã1, abolished interactions with translational elongation factor 1-¥á. Here, we report that the Y509A/F510A mutant PLC-¥ã1 displayed extremely high levels of Y783 phosphorylation and enhanced catalytic activity, compared to wild-type PLC-¥ã1, upon treatment of COS7 cells with EGF. In quiescent COS7 cells, the Y509A/F510A mutant PLC-¥ã1 exhibited a constitutive hydrolytic activity, whereas the wild-type counterpart displayed a basal level of activity. Upon treatment of COS7 cells with EGF, the Y783F mutation in Y509A/F510A PLC-¥ã1 (Y509A/F510A/Y783F triple mutant) cells also led to an enhanced catalytic activity, whereas Y783F mutation alone displayed a basal level of activity. Our results collectively suggest that the Y509A/F510A mutant is more susceptible to receptor tyrosine kinase-induced Y783 phosphorylation than is wild-type PLC-¥ã1, but no longer requires Y783 phosphorylation step for the Y509A/F510A mutant PLC-¥ã1 activation in vivo.
KEYWORD
phosphatidylinositol 4, 5-bisphosphate, phospholipase C¥ã, protein-tyrosine kinases, src homology domains
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø